Evolut r transcatheter aortic valve: FDA injury report involving AI
The FDA received a injury report involving Evolut r transcatheter aortic valve, made by Medtronic mexico s. de r.l. de cv. It was reported that 7 months following the implant of a transcatheter aortic valve, leaflet thickening was identified via computed tomography angiogram (cta) that was further analyzed via a non-medtronic artificial intelligence (ai)-powered simulation. the patient is being evaluated for a transcatheter valve-in-valve procedure.
An FDA adverse-event report linked Evolut r transcatheter aortic valve to an AI-related injury; the report requires investigation and does not by itself establish causality.
FDA adverse-event reports can be incomplete, duplicated, or unverified and do not establish that a device caused the reported outcome.
Evidence
- GovernmentFDA MAUDE report 247063462026-03-26
Truvace Impact Record TRV-2026-0047, v1: “Evolut r transcatheter aortic valve: FDA injury report involving AI.” Truvace, 2026-07-12. /record/TRV-2026-0047 (accessed at citation time). sha256 85ef2873895dc0fd…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0047 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.